Related Experiment Video
Updated: Jul 5, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Continuous vs interrupted direct oral anticoagulants for minimal bleeding-risk surgical procedures-a systematic
Alexander Xiang1, Shakil Popatia2, Sarah Lopes Sadafi3
1Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Background:
Evidence supporting the perioperative interruption of direct oral anticoagulants (DOACs) is varied, especially for procedures with minimal bleeding risk.
Objectives:
This review compared the risk of bleeding events and thromboembolism in patients undergoing minimal bleeding-risk procedures, in whom DOACs were interrupted or continued.
Methods:
Prospective, retrospective, and randomized trials examining a continuous or interrupted DOAC strategy in patients undergoing minimal bleeding-risk surgeries were included. Primary outcomes included the rates of venous or arterial thromboembolism and rates of major and minor bleeding events. Secondary outcomes included rates of surgical complications, mortality, and hospital length of stay.
Results:
We retrieved 24 studies (N = 8663 patients). Cardiac ablations were the most common procedure (n = 13), followed by pacemaker insertion (n = 4) and dental procedures (n = 4). Nineteen studies examined thromboembolic events, with a pooled odds ratio (OR) favoring continuous DOAC use (OR, 0.54; 95% CI, 0.33-0.91; I 2 = 60%), although these results failed to persist in the high-quality randomized clinical trial data. Twenty studies examined bleeding events, with a significant reduction in major bleeds favoring continuous DOACs (OR, 0.57; 95% CI, 0.37-0.87; I 2 = 0%), which failed to reach significance in the randomized data. There were no difference in minor bleeding (OR, 0.93; 95% CI, 0.69-1.24; I 2 = 0%) events. No differences were noted in the rates of total complications or mortality.
Conclusions:
While our meta-analysis found an improvement in thrombotic and major bleeding events with continuous perioperative DOAC use, these results were likely subject to selection bias with no significant differences in all outcomes in the high-quality randomized trials. The findings in the randomized data noted no significant differences between a continuous and interrupted DOAC strategy, although further research is required to provide a more definitive conclusion.
More Related Videos
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care

